Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Tissue Engineering and Applied Cell Sciences, Faculty of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Biomed Pharmacother. 2016 Dec;84:1959-1966. doi: 10.1016/j.biopha.2016.11.003. Epub 2016 Nov 8.
Glioblastoma multiform (GBM) is one of the most common and highly aggressive primary brain tumors that thought to be of glial cells origin. The new available therapy for glioblastoma is based on better understanding of molecular malignant progression in this tumor. It is better to identify key molecular targets stimulating signaling pathways that lead to initiation of apoptosis for treatment of glioblastoma. Tumorigenesis broadly is controlled by tumor microenvironment and design of best biomimetic culture systems dependency on these conditions allow for in vitro and in vivo tumor modeling for studies of cancer cells behavior to drugs. We engineered three-dimensional (3D) human tumor models using U87 glioma cells in fibrin gel that mimic microenvironmental feature of glioblastoma in vivo. In this study, atorvastatin was used as a kind of statins for induction of apoptosis, and inhibition of migration and invasion in glioma cells.
To reach for these aims, 3D model of glioma in fibrin gel was used with different concentrations of atorvastatin (1, 5, 10μM) to assay apoptotic genes expression by real time PCR and Tunel assay. After 24 and 48h exposing with different concentrations of atorvastatin, cell migration and invasion of tumor cells were investigated.
The results showed atorvastatin induced apoptosis of glioma spheroids dose- dependently. The most likely mechanisms are the induction of apoptosis by caspase-8- caspase-3 signaling pathway. The invasion and migration of U87 spheroid cells decreased after 48h especially with 10μM concentration of atorvastatin.
Finally these results suggest that this biomimetic model with fibrin may provide a vastly applicable 3D culture system to study the effect of anti-cancer drugs such as atrovastatin on tumor malignancy in vitro and in vivo and atorvastatin could be used as anticancer agent for glioblastoma treatment.
多形性胶质母细胞瘤(GBM)是最常见和高度侵袭性的原发性脑肿瘤之一,被认为起源于神经胶质细胞。新的胶质母细胞瘤治疗方法基于对这种肿瘤中分子恶性进展的更好理解。更好地识别刺激导致细胞凋亡的信号通路的关键分子靶点,对于治疗胶质母细胞瘤是非常重要的。肿瘤发生广泛受到肿瘤微环境的控制,依赖于这些条件的最佳仿生培养系统的设计允许进行体外和体内肿瘤建模,以研究癌细胞对药物的行为。我们使用纤维蛋白凝胶中的 U87 神经胶质瘤细胞设计了三维(3D)人类肿瘤模型,该模型模拟了体内胶质母细胞瘤的微环境特征。在这项研究中,阿托伐他汀被用作一种他汀类药物,以诱导神经胶质瘤细胞凋亡,并抑制其迁移和侵袭。
为了达到这些目的,使用纤维蛋白凝胶中的神经胶质瘤 3D 模型,用不同浓度的阿托伐他汀(1、5、10μM)来检测实时 PCR 和 Tunel 分析中凋亡基因的表达。在暴露于不同浓度的阿托伐他汀 24 和 48 小时后,研究肿瘤细胞的迁移和侵袭。
结果表明,阿托伐他汀诱导神经胶质瘤球体的凋亡呈剂量依赖性。最可能的机制是通过半胱天冬酶-8 半胱天冬酶-3 信号通路诱导凋亡。在 48 小时后,U87 球体细胞的侵袭和迁移明显减少,尤其是用 10μM 浓度的阿托伐他汀。
总之,这些结果表明,这种纤维蛋白仿生模型可以提供一种广泛适用的 3D 培养系统,用于研究阿伐他汀等抗癌药物对肿瘤恶性程度的体外和体内影响,阿伐他汀可作为治疗胶质母细胞瘤的抗癌药物。